Zac Al-Khateeb has been part of The Sporting News team since 2015 after earning his Bachelor's (2013) and Master's (2014) degrees in journalism at the University of Alabama. Prior to joining TSN ...

The United States upholds its status as the major global economy and richest country, with a GDP of over $30.34 trillion as of 2025, steadfastly preserving its pinnacle position from 1960 to 2025 ...

French President Emmanuel Macron on Monday fact-checked his US counterpart Donald Trump on aid for Ukraine as they met at the White House on the third anniversary of Russia's invasion. During a ...

Roivant, the source of Roche’s TL1A prospect, reported a 21% delta compared to placebo after 12 weeks. Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted rate of endoscopic ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

But those days had settled down. Or so we thought. This week, Roche made it feel like 2022 again. Just days before the AGBT meeting kicks off in Marco Island, FL, the company hosted a much ...

Alberta government ministers are as jumpy as scalded cats, fearful that the health contract scandal has spilled over to their departments. On Friday, it did. Investigative reporter Charles Rusnell ...

Roche’s innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

The 2024-25 NBA season continues following the NBA All-Star Break with nine games on Thursday. With options in the NBA DFS player pool such as Nikola Jokic, Devin Booker and Kawhi Leonard available ...

Forbes contributors publish independent expert analyses and insights. Hugh McIntyre covers music, with a focus on the global charts.

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. At Novartis, CEO Vas Narasimhan’s overall 2024 pay ...